A Randomized Controlled Phase IIb Trial of Antigen-Antibody Immunogenic Complex Therapeutic Vaccine in Chronic Hepatitis B Patients

BACKGROUND: The safety of the immune complexes composed of yeast-derived hepatitis B surface antigen (HBsAg) and antibodies (abbreviated as YIC) among healthy adults and chronic hepatitis B patients has been proved in phase I and phase IIa trial. A larger number of patients for study of dosage and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Dao-Zhen, Zhao, Kai, Guo, Li-Min, Chen, Xin-Yue, Wang, Hui-Fen, Zhang, Ji-Ming, Xie, Qin, Ren, Hong, Wang, Wen-Xiang, Li, Lan-Juan, Xu, Min, Liu, Pei, Niu, Jun-Qi, Bai, Xue-Fan, Shen, Xin-Liang, Yuan, Zheng-Hong, Wang, Xuan-Yi, Wen, Yu-Mei
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430617/
https://www.ncbi.nlm.nih.gov/pubmed/18596958
http://dx.doi.org/10.1371/journal.pone.0002565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430617/
https://www.ncbi.nlm.nih.gov/pubmed/18596958
http://dx.doi.org/10.1371/journal.pone.0002565

Ejemplares similares